S Pecora

Post‐marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years

V. Di Rienzo, M. Minelli, Antonino Musarra et al. · Clinical & Experimental Allergy · 2005 · 151 citations

Life Sciences, Child Health, Pediatrics +17

Sublingual immunotherapy in Parietaria pollen-induced rhinitis: a double-blind study.

C Troise, Susanna Voltolini, Andrea Canessa et al. · PubMed · 1995 · 120 citations

Life Sciences, Immunology, Pharmacology +17

Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study

G Cadario, A. Galluccio, M Pezza et al. · Current Medical Research and Opinion · 2007 · 70 citations

Life Sciences, Dermatology, Immunology +17

Three‐year follow‐up of clinical and inflammation parameters in children monosensitized to mites undergoing sub‐lingual immunotherapy

Fabrizio Marcucci, L. Sensi, Giuseppe Di Cara et al. · Pediatric Allergy and Immunology · 2005 · 67 citations

Life Sciences, Immunology, Pediatrics +17

Quantitative assessment of the compliance with once‐daily sublingual immunotherapy in children (<b>EASY</b> Project: <b>E</b>valuation of <b>A</b> novel <b>S</b>LIT formulation during a <b>Y</b>ear)

Giovanni Passalacqua, Antonino Musarra, S Pecora et al. · Pediatric Allergy and Immunology · 2007 · 66 citations

Pharmacy, Pediatrics, Pharmacotherapy +11